Comparison of the outcome and morbidity for localized or locally advanced prostate cancer treated by high-dose-rate brachytherapy plus external beam radiotherapy (EBRT) versus EBRT alone

Japanese Journal of Clinical Oncology

Volumn 38, Issue 7, 2008, Pages 474-479

  Fang, Fu Min ^a   Wang, Yu Ming ^a   Wang, Chong Jong ^a   Huang, Hsuan Ying ^a   Chiang, Po Hui ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

External beam radiotherapy; High dose rate brachytherapy; Prostate cancer

Indexed keywords

ANTIANDROGEN; CORTISONE; GONADORELIN AGONIST;

AGED; ARTICLE; BLOOD TRANSFUSION; BRACHYTHERAPY; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; GASTROINTESTINAL TOXICITY; HIGH DOSE RATE BRACHYTHERAPY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OUTCOME ASSESSMENT; PROGNOSIS; PROSTATE CANCER; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RECTUM HEMORRHAGE; RECURRENT CANCER; RETROSPECTIVE STUDY; TAIWAN; TRANSURETHRAL RESECTION; URINE RETENTION; UROGENITAL TRACT DISEASE;

AGED; BRACHYTHERAPY; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; GASTROINTESTINAL DISEASES; HUMANS; IRIDIUM RADIOISOTOPES; MALE; MALE UROGENITAL DISEASES; PROPORTIONAL HAZARDS MODELS; PROSTATIC NEOPLASMS; RADIOTHERAPY; RADIOTHERAPY, CONFORMAL; RETROSPECTIVE STUDIES;

EID: 48849088361     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyn056     Document Type: Article

References (21)

1. Republic of China Department of Health. Cancer Registry Annual Report. Taipei, Taiwan, Republic of China: Department of Health, Executive Yuan 2003.
2. Peschel RE, Colberg JW. Surgery, brachytherapy, and external-beam radiotherapy for early prostate cancer. Lancet Oncol 2003;4:233-41.
3. Dearnaley DP, Khoo VS, Norman AR, Meyer L, Nahum A, Tait D, et al. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: A randomized trial. Lancet 1999;353:267-72.
4. Zelefsky MJ, Wallner KE, Ling CC, Raben A, Hollister T, Wolfe T, et al. Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer. J Clin Oncol 1999;17:517-22.
5. 192Iridium prostate brachytherapy: Feasibility report. Int J Radiat Oncol Biol Phys 1998;41:525-33.
6. Akimoto T, Katoh H, Noda SE, Ito K, Yamamoto T, Kashiwagi B, et al. Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity. Int J Radiat Oncol Biol Phys 2005;63:472-8.
7. Chen YC, Chuang CK, Hsieh ML, Chen WC, Fan KH, Yeh CY, et al. High-dose-rate brachytherapy plus external beam radiotherapy for T1 to t3 prostate cancer: An experience in Taiwan. Urology 2007;70:101-5.
8. Chiang PH, Fang FM, Wang CJ, Yu TJ, Chuang YC, Wang HJ. High-dose rate iridum-192 brachytherapy and external beam radiation therapy for prostate cancer with or without androgen ablation. Int J Urol 2004;11:152-8.
9. D'Amico AV, Desjardin A, Chung A, Chen MH. Assessment of outcome prediction models for localized prostate cancer in patients managed with external beam radiation therapy. Semin Urol Oncol 1998;16:153-9.
10. Roach M, III, Hanks G, Thames H, Jr, Schellhammer P, Shipley WU, Sokol GH, et al. Defining biochemical failure following radiotherapy with or without hormone therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 2006;65:965-74.
11. Rubin P, Constine LS, Fajardo LF, Phillips TL, Wassweman TH. RTOG Late Effects Working Group. Overview. Late Effects of Normal Tissue (LENT) scoring system. Int J Radiat Oncol Biol Phys 1995;31:1041-2.
12. Soumarová R, Homola L, Perková H, Stursa M. Three-dimensional conformal external beam radiotherapy versus the combination of external radiotherapy with high-dose rate brachytherapy in localized carcinoma of the prostate: Comparison of acute toxicity. Tumori 2007;93:37-44.
13. Hoskin PJ, Motohashi K, Bownes P, Bryant L, Ostler. High dose rate brachytherapy in combination with external beam radiotherapy in the radical treatment of prostate cancer: Initial results of a randomized phase three trial. Radiother Oncol 2007;84:114-20.
14. Storey MR, Pollack A, Zagars G, Smith L, Antolak J, Rosen I. Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trial. Int J Radiat Oncol Biol Phys 2000;48:635-42.
15. Wachter S, Gerstner N, Goldner G, Pötzi R, Wambersie A, Pötter R. Rectal sequelae after conformal radiotherapy of prostate cancer: dose-volume histograms as predictive factors. Radiother Oncol 2001;59:65-70.
16. Tucker SL, Cheung R, Dong L, Liu HH, Thames HD, Huang EH, et al. Dose-volume response analyses of late rectal bleeding after radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2004;59:353-65.
17. Peters ST, Hoogeman MS, Heemsbergen WD, Hart AA, Hoogeman MS, Lebesque JV. Rectal bleeding, fecal incontinence, and high stool frequency after conformal radiotherapy for prostate cancer: Normal tissue complication probability modeling. Int J Radiat Oncol Biol Phys 2006;66:11-9.
18. Zelefsky MJ, Lyass O, Fuks Z, Wolfe T, Burman C, Ling CC, et al. Predictors of improved outcome for patients with localized prostate cancer treated with neoadjuvant androgen ablation therapy and three-dimensional conformal radiotherapy. J Clin Oncol 1998;16:3380-5.
19. Peddada AV, Jennings SB, Faricy PO, Walsh RA, White GA, Monroe AT. Low morbidity following high dose rate brachytherapy in the setting of prior transurethral prostate resection. J Urol 2007;178:1963-7.
20. Herold DM, Hanlon AL, Hanks GE. Diabetes mellitus: A predictor for late morbidity. Int J Radiat Oncol Biol Phys 1999;43:473-4.
21. Vavassori V, Fiorino C, Rancati T, Magli A, Fellin G, Baccolini M, et al. Predictors for rectal and intestinal acute toxicity during prostate cancer high-dose 3D-CRT: Results of a prospective multicenter study. Int J Radiat Oncol Biol Phys 2007;67:1401-10.